Neutralizing and/or adcc mediating monoclonal hiv antibody

Details Neutralizing and/or adcc mediating monoclonal hiv antibody Neutralizing and/or adcc mediating monoclonal hiv antibody

C - Chemistry, Metallurgy

12

P

C12P 21/08 (2006.01) A61K 39/40 (2006.01) C07K 14/16 (2006.01) C07K 16/10 (2006.01) C12N 5/18 (2006.01) G01N 33/569 (2006.01) G01N 33/577 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2073963

2073963 9111198 PCTABS00006 Monoclonal antibodies (MAbs) to human immunodeficiency virus (HIV) mediating neutralization of HIV and/or antibody-dependant cellular cytotoxity to HIV, a method to prepare these MAbs and hybridomas producing these MAbs are disclosed. The MAbs have utility i.a. in preventing spread of HIV infections, as a passive or active vaccine, for assay of HIV antigens, and to identify a neutralizing epitope in preparations for immunization.

Affiliated with

Also associated with

Rating

Neutralizing and/or adcc mediating monoclonal hiv antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neutralizing and/or adcc mediating monoclonal hiv antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutralizing and/or adcc mediating monoclonal hiv antibody will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2059206